Organovo

This stock is initiated at a Buy rating and slipped recently as a result of a secondary stock offering. Organovo Holdings Inc. (NYSEMKT: ONVO) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The company develops 3D human disease models through internal development and in collaboration with pharmaceutical and academic partners. Organovo believes these 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost.

The Jefferies analysts feel that the company’s 3D printed human tissues offer clear advantages over current traditional methods for drug discovery and toxicology testing. They report that Organovo’s first commercial products for the liver uptake has been positive and they have been getting solid interest from top major pharmaceutical companies in recent years. The analysts also think that the liver and kidney could each be $100 million plus products on very minimal penetration.

ALSO READ: The Best and Worst Performing Stocks of 2015

The Jefferies price target for this very interesting but very aggressive stock is $5, and the consensus is posted at $5.33. Shares ended last week at $3.74.

TEGNA

This company is the broadcasting and digital business of the former Gannett. TEGNA Inc. (NYSE: TGNA) spun off the publishing unit of the company to shareholders, which will continue to be called Gannett, and includes such properties as the well-known USA Today newspaper. Gannett now provides content through the flagship USA Today and will also include 92 local U.S. daily publications. TEGNA continues to own and service 46 television stations and its digital business consists of several other well-positioned and growing online companies such as Cars.com and CareerBuilder, among others.

The Jefferies analyst feel the after spinning off the publishing business, the company is in a tremendous position versus peers as they see the marriage of the broadcasting and the digital segment offering high-growth potential and outstanding free cash flow. They also highlight political ad spending next year as a huge positive for earnings with the company’s presence in six key swing states.

TEGNA investors are paid a solid 2.52% dividend. The Jefferies price target for the stock is $35, and the consensus is at $37.38. Shares closed at $31.75.

ALSO READ: 5 Oil and Gas Stocks Analysts Want You to Buy Now

The Jefferies growth calls are very aggressive and are only for accounts that are styled that way. However, they also have big upside potential and could be trading much higher than current targets if all the current potential is met or exceeded.